CME Information
Overview
Provider Statement
This continuing medical education activity is provided by 
Support Statement
This activity is supported by an educational grant from Lilly.
Target Audience
The intended audience for this activity is endocrinologists, obesity specialists, internists, family medicine physicians, general practice physicians, nurse practitioners, physician assistants, and other health care professionals involved in the management of patients with type 2 diabetes and obesity.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Examine the association between T2D and obesity, including the rationale for overcoming clinical inertia and the significance of early treatment intensification in the reduction of long-term risks and complications associated with both conditions.
- Assess practical weight loss strategies for patients with T2D.
Activity Chair
Robert F. Kushner, MD, MS, FACP, FTOS, DABOM
Professor, Departments of Medicine and Medical Education
Northwestern University Feinberg School of Medicine
Director, Center for Lifestyle Medicine
Northwestern Medicine
Chicago, IL
Faculty
Jennifer B. Green, MD
Professor of Medicine
Department of Medicine, Division of Endocrinology
Duke Clinical Research Institute
Duke University School of Medicine
Durham, NC
Donna H. Ryan, MD, FACP, FTOS
Professor Emerita
Pennington Biomedical Research Center
Louisiana State University
Baton Rouge, LA
Medical Writer
Valerie Zimmerman, PhD
Planners/Reviewers
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Linda A. Giarraputo, PA-C
Accreditation
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity enables the participant to earn up to 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participants who opt-in by providing their ABIM ID and DOB (MM/DD will earn MOC points equivalent to the amount of CME credits claimed for the activity.
This activity is approved for 1.5 contact hour(s) of continuing education (which includes 0 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 22095805. This activity was planned in accordance with AANP Accreditation Standards and Policies.
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. Approval is valid from 10/31/2022 to 10/30/2023. AAPA reference number: CME-208136.
This enduring material is approved for 1 year from the date of original release, October 31, 2022, to October 30, 2023.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate, AANP Contact Hour Certificate, or AAPA Category 1 CME Certificate.
Disclosures
Vindico Medical Education adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
Activity Chair reports the following relationship(s)
Robert F. Kushner, MD, MS, FACP, FTOS, DABOM
Consultant: Altimmune, Lilly, Novo Nordisk
Independent Research Contractor: Epitomee
Faculty report the following relationship(s)
Jennifer B. Green, MD
Consultant: AstraZeneca, Boehringer Ingelheim, Lilly, Pfizer, Novo Nordisk, Sanofi/Lexicon
Independent Research Contractor (paid to institution): Boehringer Ingelheim/Lilly, Merck
Donna H. Ryan, MD, FACP, FTOS
Advisor: Altimmune, Calibrate, Lilly, Novo Nordisk, Real Appeal, Wondr Health, Xeno, YSOPIA, Zealand
Consultant: Amgen, Epitomee, IFA Celtic, Scientific Intake, Zealand
Speaker Contracted by Ineligible Company: Novo Nordisk
Individual Stocks and Stock Options: Calibrate, Epitomee, Scientific Intake
Clinical Trial Steering Committee: Novo Nordisk
Medical Writer reports the following relationship(s)
Valerie Zimmerman, PhD
No relevant financial relationships to disclose.
Planners/Reviewers report the following relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Linda A. Giarraputo, PA-C
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
The articles in this eMonograph were composed by medical writer Valerie Zimmerman, PhD, based on the presentations of Drs. Green, Kushner, and Ryan at a virtual recording held on June 30, 2022. The eMonograph has been approved by each of the faculty individually as an accurate representation of their presentations.
Unlabeled and Investigational Usage
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2022 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com